The immune system-based cybersecurity software spinout based on University of Cambridge research has now raised about $180m in total.

Darktrace, a UK-based cybersecurity software developer based on research by a group of mathematicians at University of Cambridge, raised $75m in a series D round yesterday.

The round was led by venture capital firm Insight Venture Partners, while VC firm TenEleven Ventures and investment firms Summit Partners and KKR also participated. The deal valued Darktrace at $825m, according to Fortune.

Darktrace has created an enterprise cybersecurity platform it calls Enterprise Immune System that is equipped with machine learning algorithms based…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?